DCVC Opportunity Fund II GP, LLC - RECURSION PHARMACEUTICALS IN ownership

RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 146 filers reported holding RECURSION PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is 0.32 and the average weighting 2.3%.

Quarter-by-quarter ownership
DCVC Opportunity Fund II GP, LLC ownership history of RECURSION PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2022$42,040,000
+30.7%
3,951,1410.0%54.37%
+14.9%
Q2 2022$32,162,000
+13.7%
3,951,1410.0%47.32%
+50.0%
Q1 2022$28,290,000
-58.2%
3,951,1410.0%31.54%
-7.0%
Q4 2021$67,683,0003,951,14133.92%
Other shareholders
RECURSION PHARMACEUTICALS IN shareholders Q3 2022
NameSharesValueWeighting ↓
Kinnevik AB (publ) 10,405,668$79,603,360100.00%
Data Collective IV GP, LLC 5,941,120$45,449,56843.00%
MIC Capital Management UK LLP 8,451,758$64,655,95214.74%
MV Management XI, L.L.C. 788,762$6,034,02910.04%
ArchPoint Investors 1,047,386$8,012,5033.06%
Connective Portfolio Management, LLC 33,000$252,0000.77%
PLATINUM INVESTMENT MANAGEMENT LTD 2,335,132$17,863,7600.70%
Diametric Capital, LP 136,331$1,042,9320.44%
ARK Investment Management 6,876,598$52,605,9730.40%
ALLEN OPERATIONS LLC 217,657$1,665,0760.37%
View complete list of RECURSION PHARMACEUTICALS IN shareholders